Monoclonal antibody AFP-I-131Alternative Names: ImmuRAIT AFP-I-131
Latest Information Update: 17 Aug 2001
At a glance
- Originator Immunomedics
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Ionising radiation emitters
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Liver cancer
Most Recent Events
- 17 Aug 2001 Discontinued-II for Liver cancer in USA (Unknown route)